Asset Allocation

As of May 31, 2026.
Type % Net
Cash 1.31%
Stock 52.35%
Bond 46.15%
Convertible 0.00%
Preferred 0.11%
Other 0.08%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.30%    % Emerging Markets: 0.22%    % Unidentified Markets: 1.48%

Americas 96.70%
96.53%
Canada 84.07%
United States 12.46%
0.17%
As of May 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 1.56%
United Kingdom 0.74%
0.81%
Belgium 0.00%
Denmark 0.02%
Finland 0.00%
France 0.44%
Germany 0.03%
Ireland 0.04%
Italy 0.03%
Netherlands 0.05%
Norway 0.03%
Spain 0.02%
Sweden 0.01%
Switzerland 0.04%
0.00%
0.01%
Israel 0.00%
Greater Asia 0.26%
Japan 0.09%
0.09%
Australia 0.09%
0.08%
Hong Kong 0.02%
Singapore 0.06%
0.00%
Unidentified Region 1.48%

Bond Credit Quality Exposure

AAA 30.18%
AA 13.95%
A 16.34%
BBB 15.32%
BB 9.66%
B 6.91%
Below B 1.93%
    CCC 1.78%
    CC 0.13%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.02%
Not Rated 0.57%
Not Available 5.12%
Short Term 0.00%
As of May 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
57.37%
Materials
21.40%
Consumer Discretionary
4.96%
Financials
30.11%
Real Estate
0.90%
Sensitive
29.16%
Communication Services
0.28%
Energy
6.72%
Industrials
15.62%
Information Technology
6.54%
Defensive
3.78%
Consumer Staples
2.85%
Health Care
0.81%
Utilities
0.12%
Not Classified
5.35%
Non Classified Equity
5.35%
As of May 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of May 31, 2026
Type % Net
Government 25.10%
Corporate 47.52%
Securitized 2.09%
Municipal 20.33%
Other 4.97%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
2.82%
Less than 1 Year
2.82%
Intermediate
69.31%
1 to 3 Years
14.68%
3 to 5 Years
19.98%
5 to 10 Years
34.66%
Long Term
27.10%
10 to 20 Years
10.52%
20 to 30 Years
11.23%
Over 30 Years
5.35%
Other
0.77%
As of May 31, 2026
View Bond Maturity Exposure
Start Trial